Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Global: Current Parent Summary

Current Parent Company Name: Astellas Pharma
Ownership Structure: publicly traded
Headquartered in: Japan
Major Industry: pharmaceuticals
Specific Industry: pharmaceuticals
Penalty total since 2010 in U.S. dollars$209,000,102
Number of records: 8
Top 5 JurisdictionsPenalty Total (USD)Number of Records
United States$208,930,0007
France$70,1021
Top 5 Offense GroupsPenalty Total (USD)Number of Records
government-contracting-related offenses$208,930,0007
competition-related offenses$70,1021

Individual Penalty Records:

Click on the company or penalty amount for more information on each case.

Download results as CSV or XML
CompanyCurrent Parent IndustryOffense CategoryYearJurisdictionPenalty Amount (USD)
Astellas Pharma US Inc.pharmaceuticalsgovernment contracting fraud2019United States$100,000,000
OSI Pharmaceuticals LLCpharmaceuticalsgovernment contracting fraud2016United States$67,000,000
OSI Pharmaceuticals LLCpharmaceuticalsgovernment contracting fraud2016United States$33,500,000
Astellas Pharma US Inc.pharmaceuticalsgovernment contracting fraud2014United States$7,300,000
Astellas Pharma US Inc.pharmaceuticalsgovernment contracting fraud2014United States(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Penalty totals are adjusted to avoid double-counting. $3,100,000
OSI Pharmaceuticals LLCpharmaceuticalsgovernment contracting fraud2016United States(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Penalty totals are adjusted to avoid double-counting. $2,200,000
Astellaspharmaceuticalsgovernment contracting fraud2013United States$1,130,000
Astellas Pharmapharmaceuticalsanti-competitive practices2021France$70,102
(*): Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting.